FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Trump’s Budget for FDA Could Risk Agency Collapse
03/27/2017
 
 
TXT Confirmation Hearing on Gottlieb to be Planned Soon
03/27/2017
 
 
TXT Trump Administration Abandoning User Fee Agreements
03/22/2017
 
 
TXT TV Ads Persuaded Men to Get Testosterone: Study
03/23/2017
 
 
TXT GAO to Investigate Orphan Drugs
03/22/2017
 
 
TXT 4 Former FDA Heads Criticize Drug Importation
03/20/2017
 
 
TXT Proposed Deceptive Ad Studies Have Little Practical Use: PhRMA
03/22/2017
 
 
TXT Califf Wants More Clinical Trial Education
03/21/2017
 
 
TXT Foreign Bug Outbreak Linked to Olympus Scope: LA Times
03/24/2017
 
 
TXT Law Professor Argues for Conditional Drug Approvals
03/21/2017
 
 
TXT Product Approval Summaries
03/26/2017
 
 
TXT Since Our Last Issue ...
03/26/2017
 
 
TXT Latest Federal Register Notices
03/26/2017
 
 
TXT Lilly Investing $850 Million on Lab, Manufacturing Expansion
03/24/2017
 
 
TXT Sanders, Cummings Ask for Emflaza Pricing Info
03/23/2017
 
 
TXT AdvaMedDx Reviewing Lab Test Draft Bill
03/23/2017
 
 
TXT 1 New, 21 Updated Medication Guides
03/23/2017
 
 
TXT FDA Warns USV About CGMP Violations at Daman
03/23/2017
 
 
TXT Stakeholders Suggest Drug-Device Product Guidance Changes
03/22/2017
 
 
TXT FDA Draft Guide on Delayed Graft Function in Kidney Transplants
03/22/2017
 
 
TXT Compounding Pharmacy Owner Convicted in 2012 Meningitis Outbreak
03/22/2017
 
 
TXT Attorney Disputes Increased Liability in Off-label Promotion
03/22/2017
 
 
TXT Califf Heading New Research Foundation
03/22/2017
 
 
TXT Drug Design Defect Cases Still Not Settled
03/21/2017
 
 
TXT Latest FDA Warning Letters
03/21/2017
 
 
TXT CGMP Violations at India’s USV Private Limited
03/21/2017
 
 
TXT China’s Jinan Jinda Cited for API Deviations
03/21/2017
 
 
TXT Array Bio Pulls NDA Filling Over Clinical Benefit Concerns
03/20/2017
 
 
TXT FDA Sees Rise in GMP Violations at Supplement Makers
03/20/2017
 
 
TXT Trump’s FDA External Affairs Chief Named
03/20/2017
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving